|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations. |
| 公司地址
| 1000 Mylan Boulevard, Canonsburg, PA, USA, 15317 |
| 電話號碼
| +1 724 514-1800 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.viatris.com |
| 員工數量
| 30000 |
| Dr. Corinne Le Goff, Pharm.D. |
Chief Commercial Officer |
美元 605.77K |
24/10/2025 |
| Mr. Matthew J. Maletta |
Chief Legal Officer |
-- |
03/02/2026 |
| Mr. Paul B. Campbell |
Chief Accounting Officer and and Corporate Controller |
美元 715.39K |
26/02/2026 |
| Mr. Scott A. Smith |
Director and Chief Executive Officer |
美元 1.40M |
26/02/2026 |
| Ms. Theodora Mistras |
Chief Financial Officer |
美元 809.14K |
26/02/2026 |
| Mr. Andrew Enrietti |
Chief Administrative and Transformation Officer |
-- |
24/10/2025 |
|
|
| Mr. Frank D’Amelio |
Independent Director |
26/02/2026 |
| Mr. Harry A. Korman |
Independent Director |
05/05/2025 |
| Dr. Michael Severino, M.D. |
Independent Director |
26/02/2026 |
| Mr. James M. Kilts |
Independent Director |
26/02/2026 |
| Mr. Leo Groothuis |
Independent Director |
26/02/2026 |
| Mr. Rajiv Malik |
Director |
05/05/2025 |
| Mr. Wyllie Don Cornwell |
Independent Director |
26/02/2026 |
| Mr. Mark W. Parrish |
Vice Chairman of the Board |
26/02/2026 |
| Ms. Melina E. Higgins |
Chairman of the Board |
26/02/2026 |
| Mr. David S. Simmons |
Independent Director |
26/02/2026 |
| Ms. JoEllen Lyons Dillon |
Independent Director |
26/02/2026 |
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. |
Independent Director |
26/02/2026 |
| Mr. Richard A. Mark, C.P.A. |
Independent Director |
26/02/2026 |
| Ms. Elisha W. Finney |
Independent Director |
26/02/2026 |
| Mr. Scott A. Smith |
Director and Chief Executive Officer |
26/02/2026 |
|
|
|
|
